← Open Payments lookup

AMANDEEP SINGH: Open Payments

NPI 1497197859 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$991 in 47 payments from 12 companies in 2025. Trend: 2023 $467 · 2024 $858 · 2025 $991

Food & beverage: $991
CompanyPaymentsAmount
ABBVIE INC.15$248
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$132
Neurocrine BioSciences, Inc.3$106
Lundbeck LLC4$99
Vanda Pharmaceuticals Inc.4$90
E.R. Squibb & Sons, L.L.C.4$72
Janssen Pharmaceuticals, Inc3$71
Otsuka America Pharmaceutical, Inc.2$52
Teva Pharmaceuticals USA, Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.2$44

Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, FANAPT, COBENFY, SPRAVATO, AUSTEDO XR.

Industry payments across MS — which companies pay providers there.